Cencora Inc (NYSE:COR)
$ 251.55 1.86 (0.74%) Market Cap: 48.62 Bil Enterprise Value: 49.52 Bil PE Ratio: 33.50 PB Ratio: 76.00 GF Score: 85/100

AmerisourceBergen Corp at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 09, 2020 / 07:00PM GMT
Release Date Price: $99.9 (-2.35%)
Robert Patrick Jones
Goldman Sachs Group Inc., Research Division - VP

Great. Good afternoon, everyone. Welcome to the AmerisourceBergen session.

I am Bob Jones. I cover the health care services space here at Goldman. Very excited to have AmerisourceBergen with us today. I'm joined from the company by Steve Collis, Chairman, President and CEO; and Jim Cleary, EVP and CFO; and we also have Bennett Murphy, who heads up Investor Relations.

So thank you to the 3 of you for participating this year.

Steven H. Collis
AmerisourceBergen Corporation - Chairman, President & CEO

Thank you, Bob.

Questions & Answers

Robert Patrick Jones
Goldman Sachs Group Inc., Research Division - VP

So Steve, I thought we would just jump right in. A lot of topics out there, obviously, given the current situation and how fluid things are. I thought maybe start with -- drug volumes has been a big focus area for us and for investors. And some of the data, I think, we've been tracking around the broader market

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot